ESC 365 - Thiazolidinediones decrease risk of atrial fibrillation compared to other antidiabetic treatment

ESC Premium Access

Thiazolidinediones decrease risk of atrial fibrillation compared to other antidiabetic treatment

Session: Poster session 2 - Clinic, electrocardiogram, laboratory findings cardioversion and drugs in atrial fibrillation

Topic: Atrial fibrillation (AF)

Speaker: Doctor J. Pallisgaard (Copenhagen, DK)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Jannik Langtved Pallisgaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

0 follower

25 more presentations in this session

Long-term follow up of patients with non-valvular atrial fibrillation who undergo electrical cardioversion, comparison of direct oral anticoagulants and vitamin-k antagonists.

Speaker: Miss L. Carrillo-Aleman (Torrevieja, ES)

Acute complications of elective cardioversion

Speaker: Doctor T. Hellman (Turku, FI)

Ten year follow-up results after elective electrical cardioversions in a cohort of 806 patients with atrial fibrillation (1997 to 2006)

Speaker: Doctor J. De La Chica (Malaga, ES)

Tissue differences in the atria of lone and no-lone atrial fibrillation patients

Speaker: Doctor M. Batlle Perales (Barcelona, ES)

Perioperative allopurinol reduces atrial fibrillation following coronary artery bypass graft surgery

Speaker: Doctor Z. Efendi (Cibinong, ID)

Access the full session

Poster session 2 - Clinic, electrocardiogram, laboratory findings cardioversion and drugs in atrial fibrillation

Speakers: Doctor J. Pallisgaard, Miss L. Carrillo-Aleman, Doctor T. Hellman, Doctor J. De La Chica, Doctor M. Batlle Perales...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources